(13:01 GMT) Replimune Group Price Target Raised to $9.00/Share From $6.00 by Wedbush
DO Dow Jones Newswires Replimune Group Is Maintained at Neutral by Wedbush 6/30/2026, 09:01 PM GMT+8 Dow Jones Newswires RE REPL (13:01 GMT) Replimune Group Price Target Raised to $9.00/Share From $6.00 by Wedbush Market News TradingView Replimune Group, Inc. Stock 12‑Month Price Target Raised to $8.17, Implies 30% Downside Reuters Replimune Group Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Replimune Group FY 2026: Revenue $0 Net loss $(313.9)M — 10-K Summary Quartr REPL: FDA accepted RP1 BLA resubmission; cash funds operations into 2027; strong clinical results
